Analysts: Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

233.27USD
21 May 2015
Change (% chg)

-- (--)
Prev Close
$233.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
348,078
52-wk High
$235.00
52-wk Low
$106.03

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 2.46 December 22 May 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 8 8 8
(2) OUTPERFORM 10 10 9 10
(3) HOLD 2 2 1 2
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.85 1.81 1.74 1.81

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 12 2,536.39 2,602.60 2,471.20 2,307.73
Quarter Ending Sep-15 12 2,755.43 2,920.00 2,582.70 2,323.67
Year Ending Dec-15 18 10,494.20 10,800.10 10,228.80 9,100.00
Year Ending Dec-16 18 12,717.60 13,844.00 12,014.60 9,660.51
Earnings (per share)
Quarter Ending Jun-15 16 2.46 2.54 2.41 2.70
Quarter Ending Sep-15 16 2.88 3.20 2.72 2.73
Year Ending Dec-15 18 11.18 11.55 11.00 10.62
Year Ending Dec-16 18 15.52 16.69 13.56 11.78
LT Growth Rate (%) 2 27.30 30.70 23.89 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-15 2,152.05 2,190.90 38.85 1.81
Quarter Ending Dec-14 2,227.56 2,280.00 52.44 2.35
Quarter Ending Sep-14 2,061.18 2,056.20 4.98 0.24
Quarter Ending Jun-14 2,042.62 2,041.10 1.52 0.07
Quarter Ending Mar-14 1,968.73 1,886.20 82.53 4.19
Earnings (per share)
Quarter Ending Mar-15 2.34 2.36 0.02 0.96
Quarter Ending Dec-14 2.55 2.58 0.03 1.00
Quarter Ending Sep-14 1.99 2.11 0.12 5.90
Quarter Ending Jun-14 1.90 1.91 0.01 0.49
Quarter Ending Mar-14 1.72 1.76 0.04 2.12

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 2,536.39 2,536.39 2,566.57 2,308.71 2,307.73
Quarter Ending Sep-15 2,755.43 2,755.43 2,714.72 2,365.55 2,323.67
Year Ending Dec-15 10,494.20 10,494.20 10,298.30 9,389.28 9,100.00
Year Ending Dec-16 12,717.60 12,717.60 12,426.50 10,333.00 9,660.51
Earnings (per share)
Quarter Ending Jun-15 2.46 2.46 2.46 2.55 2.70
Quarter Ending Sep-15 2.88 2.88 2.66 2.64 2.73
Year Ending Dec-15 11.18 11.18 10.69 10.47 10.62
Year Ending Dec-16 15.52 15.52 14.48 12.30 11.78

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-15 0 0 2 6
Quarter Ending Sep-15 0 0 6 2
Year Ending Dec-15 0 0 8 3
Year Ending Dec-16 0 0 11 0
Earnings
Quarter Ending Jun-15 0 0 4 5
Quarter Ending Sep-15 0 0 9 0
Year Ending Dec-15 0 0 10 0
Year Ending Dec-16 0 0 11 0

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks